JP2023536269A5 - - Google Patents
Info
- Publication number
- JP2023536269A5 JP2023536269A5 JP2023506247A JP2023506247A JP2023536269A5 JP 2023536269 A5 JP2023536269 A5 JP 2023536269A5 JP 2023506247 A JP2023506247 A JP 2023506247A JP 2023506247 A JP2023506247 A JP 2023506247A JP 2023536269 A5 JP2023536269 A5 JP 2023536269A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- complex according
- human
- complex
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063059845P | 2020-07-31 | 2020-07-31 | |
| US63/059,845 | 2020-07-31 | ||
| PCT/US2021/044052 WO2022026917A1 (en) | 2020-07-31 | 2021-07-30 | Vaccine compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536269A JP2023536269A (ja) | 2023-08-24 |
| JP2023536269A5 true JP2023536269A5 (enExample) | 2024-08-05 |
Family
ID=80036791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023506247A Pending JP2023536269A (ja) | 2020-07-31 | 2021-07-30 | ワクチン組成物及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230277646A1 (enExample) |
| EP (1) | EP4188437A4 (enExample) |
| JP (1) | JP2023536269A (enExample) |
| CN (1) | CN116457366A (enExample) |
| AU (1) | AU2021319206A1 (enExample) |
| CA (1) | CA3190428A1 (enExample) |
| WO (1) | WO2022026917A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4188437A4 (en) * | 2020-07-31 | 2024-09-25 | The Board of Trustees of the Leland Stanford Junior University | Vaccine compositions and methods of use thereof |
| WO2023168541A1 (en) * | 2022-03-09 | 2023-09-14 | Shenzhen Genius Biotech Service Co., Ltd. | Chitosan nanoparticles (cnps) and preparation method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR011700A0 (en) * | 2000-09-14 | 2000-10-05 | Austin Research Institute, The | Composition comprising immunogenic virus sized particles (VSP) |
| US8815295B1 (en) * | 2011-12-22 | 2014-08-26 | Alabama State University | Anti respiratory syncytial virus peptide functionalized gold nanoparticles |
| EP3024936B1 (en) * | 2013-07-25 | 2019-09-04 | Exicure, Inc. | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use |
| WO2017053720A1 (en) * | 2015-09-25 | 2017-03-30 | Tarveda Therapeutics, Inc. | RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF |
| CA3043775A1 (en) * | 2016-12-06 | 2018-06-14 | Universite Laval | Ultrastable gold nanoparticles for drug delivery applications and synthesis thereof |
| WO2018115527A2 (en) * | 2016-12-23 | 2018-06-28 | Curevac Ag | Mers coronavirus vaccine |
| EP4188437A4 (en) * | 2020-07-31 | 2024-09-25 | The Board of Trustees of the Leland Stanford Junior University | Vaccine compositions and methods of use thereof |
-
2021
- 2021-07-30 EP EP21850622.8A patent/EP4188437A4/en active Pending
- 2021-07-30 CN CN202180067178.6A patent/CN116457366A/zh active Pending
- 2021-07-30 AU AU2021319206A patent/AU2021319206A1/en not_active Abandoned
- 2021-07-30 CA CA3190428A patent/CA3190428A1/en active Pending
- 2021-07-30 JP JP2023506247A patent/JP2023536269A/ja active Pending
- 2021-07-30 WO PCT/US2021/044052 patent/WO2022026917A1/en not_active Ceased
- 2021-07-30 US US18/018,316 patent/US20230277646A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway | |
| Huo et al. | Pre-treatment with zirconia nanoparticles reduces inflammation induced by the pathogenic H5N1 influenza virus | |
| JP2023536269A5 (enExample) | ||
| CN102579588B (zh) | 清热解表胶囊 | |
| JP2010500291A5 (enExample) | ||
| JP2022537178A5 (enExample) | ||
| JP2013537426A5 (enExample) | ||
| CN106659805A (zh) | 通过miRNA抑制埃博拉病毒的方法 | |
| JP2017529398A5 (enExample) | ||
| CN102335375B (zh) | 一种用于治疗肺部疾病的药物组合物及其应用 | |
| TWI884297B (zh) | mRNA奈米膠囊及其用於製備抗病毒藥物的用途 | |
| JP2015515974A5 (enExample) | ||
| CN116459295A (zh) | 一种肺炎清化方及其应用 | |
| JP2023518376A5 (enExample) | ||
| EP2571367B1 (en) | Breast cancer therapy using an engineered respiratory syncytial virus | |
| CN103127361A (zh) | 一种治疗小儿喘息性肺炎的中药制剂 | |
| Ghasemzad et al. | The nano-based theranostics for respiratory complications of COVID-19 | |
| KR20200136430A (ko) | 점액 층을 가로지르는 마이크로/나노입자의 전위를 향상시키기 위한 알지네이트 올리고머의 용도 | |
| WO2022150709A1 (en) | Compositions and methods for treating viral infection | |
| CN102836266A (zh) | 一种治疗小儿支原体肺炎的口服液 | |
| Mustafa et al. | Nanobodies as Spray and Aerosol Particles: A Breakthrough in Treating Respiratory Viral Infections | |
| JP2010189301A (ja) | 新型インフルエンザ感染症に対する医薬組成物およびその利用 | |
| US20240075012A1 (en) | Compositions and methods for treating viral infection | |
| US20220401472A1 (en) | Compositions for prevention and treatment of rsv and coronavirus infection | |
| Stass et al. | Safety and pharmacokinetics of two dose strengths of ciprofloxacin dry powder for inhalation (DPI) in patients with moderate to severe COPD |